August 5, 2018
Combined Approach Offers Hope to Lung Cancer Patients Who Become Resistant to Drugs
New-generation lung cancer drugs have been effective in a large number of patients, but within about a year, the patients tend to develop resistance to the therapy. Researchers at the...
![](https://weizmann.org.au/wp-content/uploads/2017/03/Yossi-Yarden-4.jpg)
A career in cancer research recognised by Israel’s highest honour
Professor Yosef Yarden, a member of the Weizmann Institute’s Department of Biological Regulation, has been awarded the 2017 Israel Prize in Life Sciences. The Prize, which is the country’s highest…